|
4/30/2013 7:15:42 AM
|
VentriPoint Gets Health Canada License For The NRV Application For Non-Specific Heart Disease
|
|
4/17/2013 7:00:50 AM
|
VentriPoint Gets CE Mark For Major Expansion Of Its VMS Platform For Right Heart Analysis
|
|
3/21/2013 7:06:43 AM
|
VentriPoint Diagnostics Files For CE Mark And Health Canada Approvals For Database For Non-specific Heart Disease
|
|
3/21/2013 7:04:27 AM
|
VentriPoint Diagnostics Files For CE Mark And Health Canada Approvals For Its Database For Non-specific Heart Disease
|
|
3/4/2013 4:38:10 PM
|
VentriPoint Diagnostics Announces Private Placement Of 20 Mln Units C$0.10/share For Gross Proceeds Of C$2 Mln
|
|
3/1/2013 9:03:22 AM
|
VentriPoint Diagnostics Receives US-FDA Acceptance For Pulmonary Arterial Hypertension
|
|
3/1/2013 9:03:01 AM
|
VentriPoint Receives US-FDA Acceptance Of 510 (K) Submission For Pulmonary Arterial Hypertension
|
|
3/1/2013 7:01:34 AM
|
VentriPoint Diagnostics Appoints Ellen Briant As CFO And Corporate Secretary
|
|
2/25/2013 7:06:07 AM
|
VentriPoint Diagnostics Completes Development Of New Analysis Product For Cardiac Magnetic Resonance Imaging
|
|
1/31/2013 6:41:54 PM
|
VentriPoint Announces FDA 510(K) Submission For VMS Heart Analysis System For Pulmonary Arterial Hypertension
|
|
9/20/2012 7:02:41 AM
|
VentriPoint Diagnostics Acquires VentriPoint Heart Analysis System
|
|
9/4/2012 3:50:13 PM
|
VentriPoint Diagnostics To Announce Final Results From VentriPoint Pilot Study In Pulmonary Arterial Hypertension
|
|
6/9/2012 11:35:55 AM
|
VentriPoint Diagnostics Multi-Centre Clinical Trial Focuses On Ultrasound Diagnostic Tool For Heart Analysis
|
|
6/9/2012 1:50:28 AM
|
|